NCT00001474View on ClinicalTrials.gov

Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 1995

Study Completion Date

March 31, 2002

Conditions
HIV Infection
Interventions
DRUG

Interleukin-2

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001474 - Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients | Biotech Hunter | Biotech Hunter